Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. - Vincent J; Bernard GR; Beale R; Doig C; Putensen C; Dhainaut J; Artigas A; Fumagalli R; Macias W; Wright T; Wong K; Sundin DP; et al. (Critical Care Medicine, 2005)